We studied skewing of light chain ratios (LCRs) 
We studied skewing of light chain ratios (LCRs) in germinal center cells (GCCs) relative to mantle cells (MCs) by flow cytometry (FC) in 98 reactive lymphoid tissues. LCRs were assessed using a 4-color lambda/kappa/CD20/CD38 tube. GCCs and MCs
Multiparameter flow cytometry is a powerful tool for the characterization of various hematolymphoid cell populations. In particular, differential analysis of antigen expression on immunophenotypically defined cell populations may be performed. However, knowledge of the normal immunophenotypic variability among various subsets is essential for accurate interpretation.
Flow cytometry is used commonly in combination with clinical, morphologic, and immunohistochemical data in the evaluation of hematolymphoid disorders. Mature B-lineage lymphoid neoplasms typically are differentiated from reactive processes by the identification of a light chain-restricted population. The "normal" range that generally is used for kappa/lambda ratios in reactive lymphoid tissues is between 0.8 and 2.2. It has been suggested that the kappa/lambda ratios of some reactive lymphoid tissues may be as low as 0.3 and as high as 7.0. 1 Ratios of more than 3.0 or less than 0.5 have been used in several studies to signify the presence of a clonal B-cell process. 2, 3 In our routine flow cytometric analyses, kappa/lambda ratios outside the range of 1.0 to 2.0 are noted, and the B-lymphocyte populations are studied thoroughly for aberrance.
Germinal center cells (GCCs) and mantle cells (MCs) are immunophenotypically distinct subsets of B lymphocytes. GCCs commonly are defined by their expression of CD10. They also show increased density of CD20 and CD38 compared with MCs 4 and frequently form a distinct cluster based on these antigens. We routinely assess the light chain expression patterns in GCCs and MCs by using a 4-color antibody combination of CD20, CD38, kappa, and lambda. During the past few years, we have observed cases of reactive lymphoid tissues that showed substantial differences between the kappa/lambda ratios of GCCs and MCs. On initial examination, this may suggest the possibility of a neoplastic process. In the present study, we analyzed the light chain expression patterns of GCCs and MCs in morphologically confirmed reactive lymphoid tissues to assess the degree of allowable skew. 
Materials and Methods

Samples
Immunophenotypic Analysis
Fresh tissue was processed through a mesh filter (<100 µm), and the cells were resuspended in 5% newborn calf serum in RPMI 1640 tissue culture medium (Life Technology, Rockville, MD). Cell counts were performed manually, and 500,000 cells per tube were washed with a phosphate buffered saline solution containing 0.0455% sodium azide and 0.1% bovine serum albumin (PAB). The cells then were incubated with a 4-color combination of antibodies. Antibodies against CD2 (55.2), CD3 (SK7), CD4 (SK3), CD5 (L17F12), CD7 (4H9), CD8 (SK1), CD10 (W8E7), CD19 (SJ25C1), CD20 (L27), CD38 (HB7), CD45 (2D1), CD45RO (UCHL-1), and monoclonal kappa (TB28-2) and lambda (I-155-2) immunoglobulins were obtained from Becton Dickinson (San Jose, CA). Antibodies against FMC7, CD23 (B6), and polyclonal kappa (goat) and lambda (goat) immunoglobulins were obtained from CoulterImmunotech (Hialeah, FL). Anti-CD30 (BerH2) was obtained from DAKO (Carpinteria, CA). These antibodies were conjugated with fluorescein isothiocyanate (FITC), phycoerythrin (PE), peridinin chlorophyll protein (PerCP), or allophycocyanin (APC). The expression of kappa and lambda light chains was determined in a tube containing polyclonal lambda (pL)-FITC/polyclonal kappa (pK)-PE/CD20-PerCP/CD38-APC.
Specimens were incubated at 2°C to 8°C in the dark for 20 minutes, washed with PAB, and resuspended in phosphate-buffered saline containing 1% paraformaldehyde.
Data Analysis
Flow cytometric data were acquired using a 4-color FACSCalibur flow cytometry instrument with CellQuest software (Becton Dickinson) and analyzed using Paint-aGate software (Becton Dickinson). Specific cell populations were identified using cluster analysis, various antigen expression patterns, and forward and side angle light-scatter properties. Nonviable cells and debris were removed based on forward and orthogonal light-scatter properties.
B lymphocytes were identified by the expression of CD19 after the exclusion of CD38 bright plasma cells (CD10/CD19/CD20/CD38) or CD20 (pL/pK/CD20/CD38). Nonlymphocyte events were removed based on forward and side light-scatter properties ❚Image 1A❚. GCCs were identified as a discrete population distinct from MCs on the basis of increased CD20 and CD38 antigen intensity (pL/pK/CD20/CD38) (Image 1A) ❚Image 1B❚. The separation of GCCs from MCs was validated by their CD10 expression in the tube containing CD10/CD19/CD20/CD38 ❚Image 2❚. The percentage of total B cells (of all events) was determined on CD10/CD19/CD20/CD38 and forward scatter after the elimination of debris. The percentage of GCCs equaled the number of GCC events divided by the total number of B-cell events. The mean channel number of forward light scatter was recorded for MC and GCC populations (Image 1). Kappa/lambda ratios for GCCs and MCs in each case were determined in the pL/pK/CD20/CD38 tube (Image 1). After identification of B cells based on CD20 and light scatter, discrete kappa and lambda clusters were assigned different colors, and the ratio of events in the 2 clusters was calculated. 
Statistical Analysis
The kappa/lambda light chain ratios in cases with and without GCC populations were compared using a t test. The size of GCCs vs MCs was compared using a paired sample t test. The 2-tailed Fisher exact test was used to compare age, sex, and HIV status between convergent and distinct GCC cases. Spearman correlation coefficients were calculated for the remaining various combinations of continuous variables.
Results
Patient Characteristics
The mean age of the 94 patients with 98 reactive lymphoid tissue specimens was 32 years (range, 9 months to 78 years). There were 49 females and 45 males.
Of the 65 cases with GCC and MC populations for comparison, 22 cases showed convergence of the GCC light chain clusters (see next paragraph) ❚Image 3❚. Comparison of these 22 cases with the 43 cases with distinct GCC kappa and lambda populations showed no significant difference in age (P = .40) or sex (P = .71) ❚Table 2❚. In 7 of 22 convergent cases and 5 of 43 distinct cases, there was a submitted history of HIV infection (P = .087) ( Table 2) .
Specimen Characteristics
Of 98 cases of reactive lymphoid tissues, 33 (34%) were composed solely of MCs with no discernible GCC population ❚Image 4❚, precluding comparison of GCC and MC kappa/lambda ratios. The other 65 cases (66%) showed distinct GCC and MC populations based on CD20 and CD38 expression (Image 2). However, 22 of these 65 cases (34%) were excluded from the final analysis because the GCC events showed convergence toward the midline on the light chain expression plot (Image 3). This convergence precluded an accurate separation of kappa and lambda clusters and the determination of a GCC kappa/lambda ratio. Forty-three cases (66%) remained for comparative analysis of kappa/lambda ratios in GCCs and MCs (Table 1) .
Comparison of GCCs and MCs
The average size of GCCs was larger than MCs in all cases based on forward light scatter (P < .001) (Image 1A). The mean percentage of GCCs (of total B cells) was 29% (range, 4%-81%), and in the majority of cases, they showed dimmer surface immunoglobulin expression than the MCs. The mean kappa/lambda ratio in the 43 cases containing GCCs and MCs was 1.65 (range, 1.18-2.69) vs 1.46 (range, 1.00-1.98) in the 33 cases composed of only MCs (P = .009) ❚Table 3❚. Of the 43 cases with GCC populations, 7 (16%) showed overall kappa/lambda ratios more than 2.0 vs none of 33 cases with MCs only (P = .017). No cases in either group had a kappa/lambda ratio less than 1.0.
For GCCs, the mean kappa/lambda ratio was 1.78 (range, 1.10-3.07) vs 1.56 (range, 1.00-2.24) for MCs (P = .001) ( Table 3) . The difference between the GCC and MC kappa/lambda ratios exceeded 20% in 19 (44%) of 43 cases. The largest difference was 80% (1.00 in MCs vs 1.80 in GCCs). Of the 19 cases, 14 showed higher ratios for GCCs than for MCs; and 5 GCC ratios were lower than MC ratios.
Of the 65 cases with GCCs and MCs for evaluation, 12 were submitted with a history of HIV infection. HIV+ cases had a higher mean percentage of GCCs (48%) than the HIV negative cases (25%) (P = .006). In the 43 cases with distinct GCC and MC light chain populations, the kappa/lambda ratio was significantly higher in the HIV+ cases than in the HIV-cases (1.37 vs 1.12; P = .04).
❚Figure 1❚ depicts the GCC kappa/lambda ratio vs the MC kappa/lambda ratio. The ratio of the GCC kappa/lambda ratios to that of the MCs correlated positively with the proportion of GCCs (R = 0.47; P = .001) ❚Figure 2❚. 
Clinical Follow-up
Clinical follow-up was available for 41 of the 65 patients with distinct GCC and MC populations, including 15 of 22 cases with convergent GCC light chain clusters. All patients lacked any evidence of lymphoma from 1 to 58 months (median, 30 months) after the reactive tissue biopsies. Of the 41 patients with follow-up, 3 had a history of large B-cell lymphoma (LBCL). Two were patients with HIV infection who had LBCL diagnosed in the nasopharynx and retroperitoneum 1 month and 2 years previously, respectively. The reactive lymph nodes in both showed convergent light chain clusters in the GCCs. These patients were alive and free of lymphoma 38 and 26 months, respectively, after the reactive lymph node excisions. The third patient was HIV-and had an LBCL of the parotid gland diagnosed 7 years earlier. The reactive lymph node has distinct GCC light chain clusters. This patient was alive and free of lymphoma 28 months after the reactive lymph node excision.
One HIV+ patient had a concurrent diagnosis of LBCL of the spleen with highly anaplastic features diagnosed on fine-needle aspiration. The left axillary lymph node that was excised within several days of the splenic fine-needle aspiration showed convergent GCC light chain clusters. 
Discussion
Multiparameter flow cytometry can readily distinguish GCCs from MCs by their expression of CD10 and increased density of CD20 and CD38; each B-cell subset may form a distinct cluster based on those antigens. In this retrospective 4-color flow cytometric study, we analyzed the kappa/lambda light chain ratios of GCCs and MCs in reactive lymphoid tissues and found that they may differ substantially. In addition, the kappa/lambda ratio of GCCs may exceed the ranges commonly used to distinguish benign and neoplastic processes. Thus, knowledge of the normal variability in light chain ratios and the differential antigen expression of immunophenotypically distinct groups is critical for accurate interpretation.
Mature B-cell neoplasms are detected immunophenotypically as populations with B-lineage surface markers and immunoglobulin light chain restriction. In many instances, neoplastic populations form cell clusters distinct from normal B cells on the basis of aberrant expression of 1 or more lymphoid antigens. In such circumstances, these discrete populations express 1 light chain exclusively and are detectable even in the presence of a background of polyclonal B lymphocytes. However, when neoplastic populations lack overt aberrance, they typically will be detected as increases or decreases in the kappa/lambda ratio of the entire B-cell population. In flow cytometry-based studies Maiese et al 4 and Kaleem et al 5 reported kappa/lambda ranges of 0.98 to 2.27 and 0.6 to 2.2, respectively, for reactive lymph nodes. Values for the kappa/lambda ratio of more than 3.0 or less than 0.5 have been used to signify a B-cell neoplastic proliferation. 2, 3, 5 In lymphoid tissues containing distinct GCCs and MCs, we found a statistically significant difference between the kappa/lambda ratios of these populations (Table 3) : 44% (19/43) showed a difference of 20% or more in these ratios. The majority showed a higher ratio for the GCCs than MCs. Tissues with increasing degrees of follicular hyperplasia showed greater variability between the GCC and MC kappa/lambda ratios. Cases composed of only MCs had overall lower kappa/lambda ratios compared with cases with GCCs and MCs. These findings are consistent with the previous observation that unusually high or low kappa/lambda ratios are most likely to be seen in florid follicular hyperplasia. 1 We routinely have considered overall kappa/lambda ratios less than 1.0 and more than 2.0 worthy of additional investigation to rule out occult B-cell neoplasia. In this regard, it is notable that 7 of the 19 cases showing a difference of 20% or more between the GCC and MC kappa/lambda ratios had kappa/lambda ratios exceeding 2.0. This variability and skew in the kappa/lambda ratios of reactive lymphoid tissues should not be taken as evidence of a Bcell neoplasm. Importantly, none of our 98 cases demonstrated a kappa/lambda ratio less than 1.0.
The range of light chain ratios determined in the present study is narrower than many reported in the literature. This is likely due to methodologic differences. First, 3-or 4-color flow cytometry permits the assessment of B-cell markers (eg, CD19 or CD20) in the same tube as kappa and lambda.
This permits exclusion of non-B-cell populations that may show nonspecific staining patterns from the light chain analysis. Second, by specifically isolating kappa and lambda cell clusters, rather than relying on the number of events exceeding certain thresholds (as in quadrant analysis), an additional level of noise is removed from the analysis. We believe that this approach maximizes the precision of the light chain ratio determination.
Investigators previously have reported occasional abnormal kappa/lambda ratios in otherwise morphologically benign lymphoid tissues. [6] [7] [8] Palutke et al 6 identified 12 lymph nodes and 1 stomach from 10 patients that showed more than 25% lymphocytes bearing a single class immunoglobulin. Half of the cases subsequently were diagnosed as lymphoma or were highly suggestive of lymphoma. Levy et al 7 reported 12 examples of morphologically benign lymphoid tissues with what they considered to represent monoclonal immunoglobulin expression; at the time of publication, none of the patients had developed lymphoma. Bain and Bain 8 reported 12 cases of reactive lymph nodes with abnormal kappa/lambda ratios. Follow-up information was available for 10 of the patients. Six remained well, 1 had persistent lymphadenopathy, 1 developed non-Hodgkin lymphoma, 1 developed Hodgkin lymphoma, and 1 died of lung carcinoma and pneumonia. It has been postulated that perhaps these cases represent occasional natural instances in which a few B-cell clones predominated and expressed a similar class of immunoglobulin. 7 Data to support this hypothesis come from molecular experiments by Küppers and colleagues. 9 By using micromanipulation techniques, these authors traced B-cell development from the mantle zone through the germinal center. They identified a progressive, antigen-driven pathway from clonally diverse mantle cells to polytypic germinal center dark zone cells to a few dominant B-cell clones in the light zone. These data provide an explanation for the occasional skewed kappa/lambda ratios seen in purely reactive states. In cases of benign reactive lymphoid tissues, particularly those showing prominent follicular hyperplasia, the survival and predominance of a few high-affinity clones is therefore expected. Since kappabearing B lymphocytes are naturally more abundant, one would expect a skew more often toward the kappa than toward the lambda light chain.
As expected, we identified a trend toward kappa in the B cells of reactive lymphoid tissues. Figure 1 depicts the correlation of the GCC vs MC kappa/lambda ratios with an overall shift toward kappa. Despite the fact that this is a physiologically plausible process, we are uncertain whether this shift reflects a true biologic phenomenon or artifact based on the fact that our polyclonal kappa antibody was conjugated to a brighter fluorochrome (PE) than our lambda reagent (FITC). In populations expressing dim light chain, such as GCCs, the population defined by the brighter fluorochrome might be overestimated. To address this issue, we prospectively analyzed reactive lymphoid tissues with an antibody combination consisting of monoclonal kappa-FITC/monoclonal lambda-PE/CD20-PerCP/CD38-APC (data not shown). However, these fluorochromes did not adequately discriminate between the GCC clusters, and, therefore, we cannot be certain whether the kappa skew is a physiologic phenomenon or artifact. Nevertheless, the data from Küppers et al, 9 combined with the greater likelihood of selecting kappa-expressing B cells to become dominant clones, favor a true biologic phenomenon. In addition, a positive correlation of the ratio of the GCC kappa/lambda ratio to the MC kappa/lambda ratio with the percentage of GCCs also was found (Figure 2 ). This further suggests that as tissues become more hyperplastic, the germinal center produces a small number of dominant B cells that more often express kappa than lambda light chain.
An additional finding in this study was that GCCs tend to exhibit decreased intensity of surface immunoglobulin, which may mimic a neoplastic population with dim (or negative) surface immunoglobulin. Twenty-two of our cases displayed such a phenomenon and were excluded from the final analysis because the GCC light chain clusters converged about the midline of the dot plot, precluding reliable separation of the populations (Image 3). Correlation with other cell surface markers (CD10, CD20, CD38) will help identify these as a normal population. Of note, cases with convergent GCC light chain populations were more likely to be submitted with a history of HIV infection than those lacking this feature, although this was not found to be statistically significant. The 12 cases reported with HIV infection were found to have higher percentages of GCCs than the HIV-cases. In cases with distinct GCC light chain populations, the HIV+ cases had higher overall kappa/lambda ratios compared with the HIV-cases. Lymph nodes excised from HIV-infected individuals often show florid follicular hyperplasia. These cases may be expected to contain increased numbers of GCCs and, therefore, skews in their ratios and/or dim surface immunoglobulin expression.
It should be noted that the present study was based on excisional lymph node and other tissue biopsy specimens so that reactive histologic features could be confirmed. Therefore, our results may be strictly applicable only to such specimens. It might be expected that skews in the kappa/lambda ratio would be greater in paucicellular specimens, such as fine-needle aspirations or core biopsies.
By using a 4-color flow cytometry technique to evaluate reactive lymphoid tissues, we were able to distinguish GCCs and MCs based on CD10, CD20, and CD38 expression. We found that the GCC and MC kappa/lambda ratios may differ substantially and occasionally exceed the usual range of 1.0 to 2.0. Either subset may form a distinct cluster in the analysis, and GCCs frequently demonstrate decreased light chain expression. These findings should not be misinterpreted as occult B-lineage neoplasia.
